A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...

Bezuclastinib plus sunitinib showed favorable safety and efficacy in GIST, outperforming sunitinib alone in phase 3 Peak ...

Chemotherapeutic agents are often used to treat cancer. They combat tumor growth, but also have a number of undesirable side ...

Inhibikase Therapeutics, Inc.’s IKT share price has surged by 18.23%, which has investors questioning if this is right time ...

As Lina Khan, chair of the Federal Trade Commission, ends her tenure this week the FTC posted a second report in six months ...

Tenax Therapeutics focuses on addressing cardiovascular and pulmonary diseases with high unmet medical needs. Besides ...

Tenax Therapeutics’ management will also participate in one-on-one investor meetings. To request a one-on-one meeting at the conference, please contact your Guggenheim representative. The live and ...

Kura Oncology's stock plummeted 50% after announcing a collaboration with Kyowa Kirin, making it a less attractive ...

The FTC report found that from 2017 to 2022, three PBMs—UnitedHealth Group's Optum, CVS Health's CVS Caremark and Cigna's ...

Olverembatinib demonstrated activity in patients with CP-CML who received first- or second-generation TKIs as first-line therapy.

Shares of Tenax Therapeutics, Inc. (NASDAQ:TENX – Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $4.54 and traded as ...